Consultation record · APT-260714-05
Tuesday, 14 July 2026 at 01:15 · Dr. Elena Park · Internal Medicine
Routine laboratory follow-up
No edema or urinary change reported.
Clinically euvolemic.
Stable symptoms; renal panel result pending.
Chronic kidney disease stage 3
Not applicable
Review renal panel when available.
Maintain planned follow-up after laboratory result.
Losartan · 50 mg
Oral · Once daily · 90 days
Continue as documented pending renal-panel review.
Creatinine
PendingPending mg/dL · Ref. Laboratory-specific
None recorded
None recorded
2026-07-24
Electronic signature area · demonstration only